News Agency
The Times

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

  • Written by PR Newswire

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Oricell Therapeutics Co., Ltd ("Oricell" or "the Company"), a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, today announced the close of a $45M Series B1 investment round after the completion of a $125M Series B fund-raise in July 2022. The...

Read more: Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

How Healthcare Specialization is Reshaping Medical Practice in the UAE

The healthcare landscape in the United Arab Emirates has undergone a dramatic transformation over the past decade, driven by strategic investments in specialized medical services and international partnerships. As the region positions itself as a global healthcare hub, the shift... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion